Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Chemed Inc (CHE)

Chemed Inc (CHE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 5,073,642
  • Shares Outstanding, K 13,765
  • Annual Sales, $ 2,530 M
  • Annual Income, $ 265,240 K
  • EBIT $ 403 M
  • EBITDA $ 468 M
  • 60-Month Beta 0.46
  • Price/Sales 2.02
  • Price/Cash Flow 15.08
  • Price/Book 5.38

Options Overview Details

View History
  • Implied Volatility 36.37% (-0.52%)
  • Historical Volatility 51.12%
  • IV Percentile 86%
  • IV Rank 66.85%
  • IV High 44.14% on 04/10/25
  • IV Low 20.69% on 01/16/26
  • Expected Move (DTE 18) 2.55 (0.68%)
  • Put/Call Vol Ratio 2.00
  • Today's Volume 12
  • Volume Avg (30-Day) 29
  • Put/Call OI Ratio 0.47
  • Today's Open Interest 507
  • Open Int (30-Day) 627
  • Expected Range 371.54 to 376.64

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate 4.99
  • Number of Estimates 1
  • High Estimate 4.99
  • Low Estimate 4.99
  • Prior Year 5.11
  • Growth Rate Est. (year over year) -2.35%

Price Performance

See More
Period Period Low Period High Performance
1-Month
365.20 +2.43%
on 03/27/26
424.85 -11.95%
on 03/03/26
-35.92 (-8.76%)
since 02/27/26
3-Month
365.20 +2.43%
on 03/27/26
481.38 -22.29%
on 02/17/26
-58.09 (-13.44%)
since 12/26/25
52-Week
365.20 +2.43%
on 03/27/26
623.60 -40.01%
on 04/03/25
-231.61 (-38.24%)
since 03/28/25

Most Recent Stories

More News
1 Profitable Stock on Our Buy List and 2 We Ignore

1 Profitable Stock on Our Buy List and 2 We Ignore

CHE : 374.09 (+1.49%)
WBD : 27.09 (+0.07%)
LRN : 84.17 (-1.68%)
Q4 Earnings Outperformers: Chemed (NYSE:CHE) And The Rest Of The Senior Health, Home Health & Hospice Stocks

Q4 Earnings Outperformers: Chemed (NYSE:CHE) And The Rest Of The Senior Health, Home Health & Hospice Stocks

CHE : 374.09 (+1.49%)
3 Out-of-Favor Stocks Walking a Fine Line

3 Out-of-Favor Stocks Walking a Fine Line

CHE : 374.09 (+1.49%)
PSKY : 8.92 (+1.48%)
FLO : 8.37 (-0.36%)
3 Reasons to Sell CHE and 1 Stock to Buy Instead

3 Reasons to Sell CHE and 1 Stock to Buy Instead

CHE : 374.09 (+1.49%)
Now Open: VITAS® Healthcare Inpatient Hospice Care at Oak Manor

LARGO, Fla. , March 16, 2026 /PRNewswire/ -- Residents in Pinellas County now have improved access to high-quality, compassionate end-of-life care with the opening of VITAS Healthcare inpatient...

CHE : 374.09 (+1.49%)
1 Unpopular Stock That Deserves Some Love and 2 We Find Risky

1 Unpopular Stock That Deserves Some Love and 2 We Find Risky

CHE : 374.09 (+1.49%)
UNF : 249.33 (+0.29%)
CTAS : 168.66 (+1.78%)
Chemed Corporation to Present at the Oppenheimer 36th Annual Healthcare Conference

CINCINNATI, March 12, 2026 (GLOBE NEWSWIRE) -- Chemed Corporation (NYSE:CHE) today announced that it will deliver a virtual presentation at the Oppenheimer 36th Annual Healthcare Conference on Thursday,...

CHE : 374.09 (+1.49%)
Stocks Finish Mostly Lower as Nvidia Weighs on Chipmakers

The S&P 500 Index ($SPX ) (SPY ) on Thursday closed down -0.54%, the Dow Jones Industrial Average ($DOWI ) (DIA ) closed up +0.03%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -1.16%. March E-mini...

AMAT : 323.12 (-4.17%)
CHE : 374.09 (+1.49%)
CELH : 33.81 (-0.38%)
AVGO : 293.41 (-2.42%)
INTU : 429.03 (+3.02%)
TTD : 22.01 (+3.43%)
DDOG : 115.81 (+1.16%)
JHG : 51.35 (-0.06%)
$IUXX : 22,953.38 (-0.78%)
ASML : 1,253.96 (-3.72%)
FICO : 1,047.94 (+3.65%)
ZNM26 : 110-300 (+0.11%)
Why Chemed (CHE) Shares Are Plunging Today

Why Chemed (CHE) Shares Are Plunging Today

CHE : 374.09 (+1.49%)
Stocks Pressured as Chipmakers Tumble

The S&P 500 Index ($SPX ) (SPY ) today is down -0.74%, the Dow Jones Industrial Average ($DOWI ) (DIA ) is up +0.13%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -1.40%. March E-mini S&P futures...

AMAT : 323.12 (-4.17%)
CHE : 374.09 (+1.49%)
CELH : 33.81 (-0.38%)
AVGO : 293.41 (-2.42%)
INTU : 429.03 (+3.02%)
TTD : 22.01 (+3.43%)
DDOG : 115.81 (+1.16%)
JHG : 51.35 (-0.06%)
$IUXX : 22,953.38 (-0.78%)
ASML : 1,253.96 (-3.72%)
FICO : 1,047.94 (+3.65%)
ZNM26 : 110-300 (+0.11%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

Relative Strength just crossed above 30%. The market has bounced from oversold territory. Beware of a potential mean reversion.

See More Share

Business Summary

Chemed Corporation purchases, operates and divests subsidiaries engaged in diverse business activities. The company's operating businesses are managed on a decentralized basis. Chemed currently operates as two wholly-owned subsidiaries: VITAS Healthcare and Roto-Rooter. VITAS Healthcare segment provides...

See More

Key Turning Points

3rd Resistance Point 383.96
2nd Resistance Point 379.27
1st Resistance Point 376.68
Last Price 374.09
1st Support Level 369.40
2nd Support Level 364.71
3rd Support Level 362.12

See More

52-Week High 623.60
Fibonacci 61.8% 524.90
Fibonacci 50% 494.40
Fibonacci 38.2% 463.91
Last Price 374.09
52-Week Low 365.20

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.